(Rac)-Indoximod (1-Methyl-DL-tryptophan) is an indoleamine 2,3-dioxygenase (IDO) inhibitor; it is used to inhibit tryptophan depletion and partially reverse the growth-inhibitory effects of IFN-γ; in combination with IFN-γ, it significantly reduces the activity of human cardiac myofibroblasts expressing α-SMA and induces apoptosis by upregulating IRF-1, Fas, and FasL gene expression.